Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Metadata
Title
Willingness to pay for improvement of physical function among rheumatoid arthritis patients as measured by Health Assessment Questionnaire
Publication date
01-03-2011
Published in
Rheumatology International / Issue 3/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1280-1

Other articles of this Issue 3/2011

Rheumatology International 3/2011 Go to the issue

Letter to the Editor

Rituximab and leflunomide for Wegener’s granulomatosis: a long-term follow-up

Original Article

Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression

Short Communication

Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two cases

Case Report

Manual lymphatic drainage in management of edema in a case with CRPS: why the(y) wait?

Letter to the Editor

SNP–SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosis

Case Report

Uveitis in celiac disease with an excellent response to gluten-free diet: third case described

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits